{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:22:33Z","timestamp":1793762553609,"version":"4.6.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Aortic regurgitation (AR) is a prevalent valvular disease. Cardiovascular magnetic resonance (CMR) imaging is emerging as an accurate and precise method for assessing AR. However, its role in guiding interventions and risk stratification for outcomes remains to be fully defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis evaluate the predictive utility of CMR-derived AR fraction (ARF) in determining intervention timing and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A systematic search identified observational studies assessing CMR-derived ARF in AR prognostication. Hazard ratios (HRs) for intervention timing, mortality, and heart failure were pooled using a random-effects model. Study heterogeneity (I\u00b2 statistic) was assessed, and publication bias was evaluated using a funnel plot. A total of 1235 studies were screened, with 12 meeting the inclusion criteria. Eight studies (n = 1996 patients) were included in the meta-analysis. ARF severity thresholds ranged from 30 to 43% (mean 33.7%). Follow-up ranged from 2 to 5.1 years. The pooled HR for clinic outcomes with an ARF &amp;gt; 33% was 4.12 (95% CI: 2.31\u20137.34, P value &amp;lt; 0.01). The highest reported HR was 24.59, while the lowest was 1.04. Studies demonstrated that a higher ARF correlates with an increased risk of adverse outcomes, supporting CMR as a key tool for risk stratification and intervention timing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CMR-derived ARF is strongly predictive of clinical outcomes. ARF &amp;gt; 33% is associated with significantly increased risk, warranting its integration into clinical decision-making frameworks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeaf349","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:58:25Z","timestamp":1765025905000},"page":"162-173","source":"Crossref","is-referenced-by-count":3,"title":["The role of CMR in the timing of aortic valve interventions and risk stratification in aortic regurgitation: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"27","author":[{"given":"Tiya","family":"Bali","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich Research Park, Norwich NR4 7UQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-3400","authenticated-orcid":false,"given":"Alexander","family":"Gall","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich Research Park, Norwich NR4 7UQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3984-5005","authenticated-orcid":false,"given":"Aradhai","family":"Bana","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich Research Park, Norwich NR4 7UQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Giulia","family":"Pavon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiocentro Ticino Institute , Ente Ospedaliero Cantonale, Via Tesserete, 48, Lugano 6900 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[{"name":"Neuroscience, Imaging and Clinical Sciences, Gabriele D'Annunzio University of Chieti and Pescara , Chieti Scalo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-4806","authenticated-orcid":false,"given":"Gareth","family":"Matthews","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich Research Park, Norwich NR4 7UQ ,","place":["UK"]},{"name":"Cardiology Department, Norfolk and Norwich University Teaching Hospitals , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-2393","authenticated-orcid":false,"given":"Dipan J","family":"Shah","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart & Vascular Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L","family":"Cavalcante","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Minneapolis Heart Institute , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Naik","sequence":"additional","affiliation":[{"name":"Cardiology Department, Indraprastha Apollo Hospitals , New Delhi ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-169X","authenticated-orcid":false,"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich Research Park, Norwich NR4 7UQ ,","place":["UK"]},{"name":"Cardiology Department, Norfolk and Norwich University Teaching Hospitals , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"2026021604520328100_jeaf349-B1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","article-title":"Epidemiology of valvular heart disease in the adult","volume":"8","author":"Iung","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2026021604520328100_jeaf349-B2","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","article-title":"Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study","volume":"103","author":"Andell","year":"2017","journal-title":"Heart"},{"key":"2026021604520328100_jeaf349-B3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/eurheartj\/ehx562","article-title":"Inter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve","volume":"39","author":"Kong","year":"2018","journal-title":"Eur Heart J"},{"key":"2026021604520328100_jeaf349-B4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.2908","article-title":"Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"25","author":"Shahim","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026021604520328100_jeaf349-B5","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2026021604520328100_jeaf349-B6","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021604520328100_jeaf349-B7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/heartjnl-2016-310819","article-title":"Evaluation of aortic regurgitation with cardiac magnetic resonance imaging: a systematic review","volume":"104","author":"Lee","year":"2018","journal-title":"Heart"},{"key":"2026021604520328100_jeaf349-B8","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/heartjnl-2014-305615","article-title":"Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation","volume":"100","author":"Ribeiro","year":"2014","journal-title":"Heart"},{"key":"2026021604520328100_jeaf349-B9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCIMAGING.112.975623","article-title":"Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography","volume":"6","author":"Cawley","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2026021604520328100_jeaf349-B11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026021604520328100_jeaf349-B12"},{"key":"2026021604520328100_jeaf349-B13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.jacc.2023.03.001","article-title":"Influence of cardiac remodeling on clinical outcomes in patients with aortic regurgitation","volume":"81","author":"Malahfji","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026021604520328100_jeaf349-B14","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.083600","article-title":"Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome","volume":"126","author":"Myerson","year":"2012","journal-title":"Circulation"},{"key":"2026021604520328100_jeaf349-B15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2016.05.059","article-title":"Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement","volume":"68","author":"Ribeiro","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026021604520328100_jeaf349-B16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jcmg.2018.08.036","article-title":"Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation","volume":"12","author":"Kammerlander","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10554-019-01682-x","article-title":"Aortic regurgitation assessment by cardiovascular magnetic resonance imaging and transthoracic echocardiography: intermodality disagreement impacting on prediction of post-surgical left ventricular remodeling","volume":"36","author":"Neisius","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mri.2020.11.011","article-title":"Cardiac MRI for the prognostication of heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"76","author":"Assadi","year":"2021","journal-title":"Magn Reson Imaging"},{"key":"2026021604520328100_jeaf349-B19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2019.04.007","article-title":"Effect of aortic regurgitation by cardiovascular magnetic resonance after transcatheter aortic valve implantation","volume":"124","author":"Ferreira-Neto","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026021604520328100_jeaf349-B20","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.jcmg.2021.04.028","article-title":"Regional replacement and diffuse interstitial fibrosis in aortic regurgitation: prognostic implications from cardiac magnetic resonance","volume":"14","author":"Senapati","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B21","doi-asserted-by":"crossref","first-page":"e014901","DOI":"10.1161\/CIRCIMAGING.122.014901","article-title":"Multiparametric strategy to predict early disease decompensation in asymptomatic severe aortic regurgitation","volume":"15","author":"Ko\u010dkov\u00e1","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamacardio.2022.2108","article-title":"Association of left ventricular remodeling assessment by cardiac magnetic resonance with outcomes in patients with chronic aortic regurgitation","volume":"7","author":"Hashimoto","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026021604520328100_jeaf349-B23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11886-024-02044-3","article-title":"Assessing regurgitation severity, adverse remodeling, and fibrosis with CMR in aortic regurgitation","volume":"26","author":"Saeed","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"2026021604520328100_jeaf349-B24","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jcmg.2022.05.006","article-title":"Differences in cardiac remodeling in left-sided valvular regurgitation","volume":"15","author":"Vejpongsa","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.amjcard.2016.12.017","article-title":"Cardiac magnetic resonance imaging versus transthoracic echocardiography for prediction of outcomes in chronic aortic or mitral regurgitation","volume":"119","author":"Harris","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026021604520328100_jeaf349-B26","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1007\/s10554-021-02255-7","article-title":"Predicting the need of aortic valve surgery in patients with chronic aortic regurgitation: a comparison between cardiovascular magnetic resonance imaging and transthoracic echocardiography","volume":"37","author":"Faber","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jacc.2023.08.051","article-title":"Imaging methods for evaluation of chronic aortic regurgitation in adults: JACC state-of-the-art review","volume":"82","author":"Ranard","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026021604520328100_jeaf349-B28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.31083\/j.rcm2412359","article-title":"Prognostic value of cardiac magnetic resonance imaging in chronic aortic regurgitation: a systematic review and meta-analysis","volume":"24","author":"Ni","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"2026021604520328100_jeaf349-B29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ehjci\/jeaa338","article-title":"A comparison of the clinical efficacy of echocardiography and magnetic resonance for chronic aortic regurgitation","volume":"23","author":"Postigo","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B30","first-page":"524","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)","volume":"75","author":"Vahanian","year":"2022","journal-title":"Rev Esp Cardiol (English Edition)"},{"key":"2026021604520328100_jeaf349-B31","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2019.01.024","article-title":"Outcomes in chronic hemodynamically significant aortic regurgitation and limitations of current guidelines","volume":"73","author":"Yang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026021604520328100_jeaf349-B32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm11010152","article-title":"Assessment of asymptomatic severe aortic regurgitation by Doppler-derived Echo indices: comparison with magnetic resonance quantification","volume":"11","author":"Hlubock\u00e1","year":"2021","journal-title":"JCM"},{"key":"2026021604520328100_jeaf349-B33","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1093\/ehjci\/jeab253","article-title":"Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper","volume":"23","author":"Lancellotti","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026021604520328100_jeaf349-B34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2021.08.045","article-title":"The usefulness of left ventricular volume and aortic diastolic flow reversal for grading chronic aortic regurgitation severity\u2014using cardiovascular magnetic resonance as reference","volume":"340","author":"Gao","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026021604520328100_jeaf349-B35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/mrm.1910370412","article-title":"Slice location dependence of aortic regurgitation measurements with MR phase velocity mapping","volume":"37","author":"Chatzimavroudis","year":"1997","journal-title":"Magn Reson Med"},{"key":"2026021604520328100_jeaf349-B36","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jcmg.2020.09.029","article-title":"CMR in evaluating valvular heart disease: diagnosis, severity, and outcomes","volume":"14","author":"Myerson","year":"2021","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf349\/65824253\/jeaf349.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/2\/162\/65824253\/jeaf349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/2\/162\/65824253\/jeaf349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:52:15Z","timestamp":1771235535000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/2\/162\/8375734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,9]]},"published-print":{"date-parts":[[2026,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeaf349","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,9]]}}}